reports
Medexus Files Business Acquisition Report
Medexus Files Business Acquisition Report MONTREAL, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced the filing of the Business Acquisition Report (“BAR”) on SEDAR () in relation to the previously announced transaction that occurred on October 16, 2018. “As can be seen in the unaudited interim financial statements (non-IFRS compliant) for the period ended Sept 30, 2018 included in the BAR, both Medexus Inc. and medac Pharma, Inc. have strong revenue growth resulting in significant positiv...
Pediapharm Announces Name Change, Consolidation and Debenture Repaymen...
Pediapharm Announces Name Change, Consolidation and Debenture Repayment NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the "Company") (TSXV: PDP, OTCQB: PDDPF) is pleased to announce that at the annual general and special meeting of shareholders held on December 12, 2018 (the "Meeting"), the Company's shareholders approved the change of ...
Pediapharm Announces Q2 Results – Record Adjusted EBITDA, Record Rev...
Pediapharm Announces Q2 Results – Record Adjusted EBITDA, Record Revenue and 13th Consecutive Year-Over-Year Quarterly Revenue Growth NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSXV: PDP, OTCQB: PDDPF) is pleased to file its second quarter financial results ended September 30, 2018. All dollar amounts are expressed in Canadian currency and res...
Pediapharm Announces Closing of Transformative Acquisitions, Diversify...
Pediapharm Announces Closing of Transformative Acquisitions, Diversifying and Expanding the Platform for Future Growth NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. ("Pediapharm") (TSXV: PDP, OTCQB: PDDPF) is pleased to announce the closing of its previously announced acquisitions of two speciality pharmaceutical companies, transforming the company through increased portfolio di...
Pediapharm Announces Closing of Subscription Receipt Offering for Tota...
Pediapharm Announces Closing of Subscription Receipt Offering for Total Gross Proceeds of $62 Million NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. ("Pediapharm") (TSXV: PDP, OTCQB: PDDPF) is pleased to announce the closing today of its previously announced private placement offering (the "Offering") of Subscription Receipts (as defined below). The Offering consisted of both a ...
Pediapharm Files Corporate Presentation
Pediapharm Files Corporate Presentation NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. ("Pediapharm") (TSXV:PDP) (OTCQX:PDDPF) announces that, further to its press release issued on September 6, 2018, it has filed a corporate presentation on its website setting out further information about the proposed acquisition of Medac Pharma, Inc. and the proposed acquisition of Medexus In...
Pediapharm Announces Transformative Acquisitions and $60 Million Offer...
Pediapharm Announces Transformative Acquisitions and $60 Million Offering of Subscription Receipts NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. ("Pediapharm") (TSXV: PDP, OTCQX: PDDPF) is pleased to announce that it has entered into definitive agreements to acquire two speciality pharmaceutical companies and also intends to complete a private placement offering for up to CDN$6...
Pediapharm Announces Q1 Results – Record Revenue and 12th Consecutiv...
Pediapharm Announces Q1 Results – Record Revenue and 12th Consecutive Year-Over-Year Quarterly Growth NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE: PDP) (OTCQB: PDDPF) is pleased to file its first quarter financial results ended June 30, 2018. All dollar amounts are expressed in Canadian currency and results are reported in accordance with IFRS accounting principles. KEY HIGHLIGHTS - PERIOD ENDED JUNE 30, 2018 In the three-month period end...
Pediapharm Announces Annual Audited Financial Results – 61% Annual R...
Pediapharm Announces Annual Audited Financial Results – 61% Annual Revenue Growth and 11th Consecutive Year-over-year Quarterly Growth NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, July 18, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE:PDP) (OTCQB:PDDPF) is pleased to announce its annual audited results for the year ended March 31, 2018. All dollar amounts are expressed in Canadian currency and results are reported in accordance with IFRS accounting principles. KEY HIGHLIGHTS - PERIOD ENDED MARC...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.